Type of Disease Treatment
  •  
Well differentiated Tumours Variety of biotherapeutic regimens (eg. Octreotide, lanreotide± IFN α)
  •  
Poorly Differentiated Tumours Chemotherapy
  •  
Primary Tumours
  • Duodenal tumour <1cm
  • Duodenal tumour ≥2cm
  • Jejunal/ileal tumour
  • Jejunal/ileal tumour >2cm/multiple
  • Appendiceal tumour <1cm
  • 1-2cm appendiceal tumour without evidence of local invasion, or tumour at base of appendix
  • Appendiceal tumour >2cm; Cecal involvement
  • Sigmoid tumour
  • Rectal tumour <1cm
  • Rectal tumour 1-2cm
  • Rectal tumour >2cm
Definitive treatment with surgical resection
  • Local excision
  • Pancreatoduodenectomy or segmental resection
  • Wide excision of bowel and adjacent mesentery (Distal ileocolectomy to adequately remove lymphatic drainage)
  • Careful search for 2nd primaries/multiple tumours, metastatic liver disease
  • Wide resection, excising all areas of lymph node drainage
  • Appendectomy
  • Appendectomy
  • Righthemicolectomy
  • Anterior resection +/- colostomy
  • Biopsy & if muscular invasion APR/LAR
  • Complete transanal excision, regularproctoscopic examinations
  • Low anterialrection / abdominoperineal resection
  •  
Presence of Distant Metastasis
  • Resectable
  • Unresectable
  • Single liver metastases
  • Multiple liver metastases
 
  • Surgery
  • Medical treatment +/- Surgical debulkment
  • Hepactectomy
  • Hepactectomy to debulk
  • Somatostatin analogue prior to hepatic artery embolisation/ligation ± 5FU to prevent carcinoid crisis
  • Systematic chemotherapy
Table 3: Treatment summary of the available literature.